CVS Health Corporation (CVS) 当前追踪市盈率 (P/E) 为 57.0, 前瞻市盈率为 10.5. 追踪盈利收益率为 1.75%, 前瞻盈利收益率 9.55%. PEG 0.03 (Peter Lynch 低估标准 ≤1.0). 格雷厄姆数为 $43.12.
本页证实的标准:
SharesGrow 综合评分： 55/100 其中 2/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | 15.9 | 2.75 | 2.30 | 0.48 | 2.17% |
| 2017 | 11.2 | 0.36 | 1.96 | 0.40 | 2.77% |
| 2018 | -115.2 | 1.06 | 1.17 | 0.35 | 2.98% |
| 2019 | 14.6 | -0.01 | 1.51 | 0.38 | 2.69% |
| 2020 | 12.5 | 1.67 | 1.29 | 0.33 | 2.93% |
| 2021 | 17.0 | 1.79 | 1.81 | 0.47 | 1.93% |
| 2022 | 28.4 | -0.63 | 1.71 | 0.38 | 2.38% |
| 2023 | 12.2 | 0.13 | 1.33 | 0.28 | 3.09% |
| 2024 | 12.2 | -0.28 | 0.75 | 0.15 | 5.97% |
| 2025 | 56.9 | -0.92 | 1.34 | 0.25 | 3.38% |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $4.90 | $177.55B | $5.32B | 3% |
| 2017 | $6.44 | $184.79B | $6.62B | 3.6% |
| 2018 | $-0.57 | $194.58B | $-594M | -0.3% |
| 2019 | $5.08 | $256.78B | $6.63B | 2.6% |
| 2020 | $5.46 | $268.71B | $7.18B | 2.7% |
| 2021 | $5.95 | $292.11B | $8B | 2.7% |
| 2022 | $3.26 | $322.47B | $4.31B | 1.3% |
| 2023 | $6.47 | $357.78B | $8.34B | 2.3% |
| 2024 | $3.66 | $372.81B | $4.61B | 1.2% |
| 2025 | $1.39 | $402.07B | $1.77B | 0.4% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $7.17 | $7.07 – $7.35 | $404.92B | $394.45B – $417.31B | 18 |
| 2027 | $8.16 | $7.96 – $8.35 | $424.63B | $408.06B – $442.04B | 17 |
| 2028 | $9.41 | $8.53 – $11.11 | $447.92B | $445.68B – $450.17B | 10 |
| 2029 | $10.47 | $10.04 – $11.09 | $475.37B | $460.55B – $497.04B | 4 |
| 2030 | $11.47 | $11.00 – $12.15 | $495.6B | $480.15B – $518.19B | 4 |
